Neurones S.A. (0GX2.L) LSE
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.23B |
| Enterprise Value | 930.43M |
| P/E Ratio | 15.75 |
| PEG Ratio | 1.73 |
| Price/Sales Ratio | 0.96 |
| Price/Book Ratio | 2.8 |
| Enterprise/Revenue | 0.67 |
| Enterprise/EBITDA | 6.18 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.06 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 857.2M |
| Revenue/Share | 30.29 |
| Gross Profit | 90.04M |
| EBITDA | 90.32M |
| Net Income | 61.9M |
| Diluted EPS | 2.14 |
Balance Sheet
| Total Cash | 301.88M |
| Total Cash/Share | 10.3 |
| Total Debt | 41.3M |
| Total Debt/Equity | 0.11 |
| Current Ratio | 2.23 |
| Book Value Per Share | 14.79 |
Price History
| 52-Week Change | -8.04 |
| 52-Week High | 46.8 |
| 52-Week Low | 32.45 |
| Moving Average 50 Days | 44.44 |
| Moving Average 200 Days | 39.82 |
Statistics
| Average Volume | 1,232 |
| Shares Outstanding | 24.25M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.4 |
| Trailing Annual Dividend Yield | 3.9 |
| Payout Ratio | 0.6 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
